Hidezo Mori – författare
Visar alla böcker från författaren . Handla med fri frakt och snabb leverans.
2 produkter
2 produkter
Häftad, Engelska, 2005
1 116 kr
Skickas inom 10-15 vardagar
The fact that the cardiovascular system transports oxygen and nutrients to all parts of the body makes any threat to its well-being a serious hazard to organs, tissues, and cells. This fundamental truth underlines the importance of research into cardiovascular regeneration and, therefore, of this collection outlining the latest developments in the field. With input from many of the leading researchers and practitioners, this book describes techniques for therapeutic angiogenesis and vasculogenesis for the treatment of ischemic diseases and examines the current approaches to angiogenic cytokines, cardiovascular stem cells, and tissue-engineering tools. The latest clinical results using bone marrow-derived mononuclear cell therapy for intractable circulatory disorders are also covered. This body of work will be a valuable resource for professionals in the fields of cardiovascular surgery, regenerative medicine, and tissue engineering.
E-bok
PDF, Engelska, 20061 459 kr
Läs direkt efter köp
The cardiovascular system transports oxygen and nutrients to all parts of the body; therefore, any impediment to this system through, for example, a circulatory disorder, represents a serious threat to organs, tissues, and cells. Obstructive diseases of vessels with a diameter of more than 1 mm can be treated by conventional surgical and interventional approaches; however, blockages in small vessels with a diameter of less than 1 mm cannot be treated by conventional methods. As a consequence, therapeutic ang- genesis and vasculogenesis for the treatment of ischemic diseases have been widely studied in the last decade. These methods may contribute to the re pair of intractable cardiovascular diseases with a main vascular involvement in the body''s smallest vessels. In this book, Hikaru Matsuda and I have tried to summarize recent Japanese developments in the field of cardiovascular regeneration therapies using tissue engineering. The Ministry of Health, Labor, and Welfare of Japan has been encouraging the National Cardiovascular Center Research Institute to promote cardiovascular regeneration therapies using such ap proaches. Therefore, it is with the financial aid and support of research grants, such as that for Cardiovascular Disease (13C-1 and I6C-6), Health and Labor Sciences Research Grants (RHGTEFB-genome-005, RHGTEFB-saisei-003, and CRCD-junkanki-009) and a grant from NEDO of Japan, that significant progress has been possible.